New Cloning Technique Can Accurately Assess Transmissibility of Future SARS-CoV-2 Mutants
Using the latest sequencing technology and PCR techniques, an international team of researchers has developed an approach that can accurately assess the transmissibility of new mutations of the SARS-CoV-2 virus. More...01 Mar 2021
Novel Calculators Identify Hospitalized COVID-19 Patients at Greatest Risk of Requiring Mechanical Ventilation or of In-Hospital Death
Two novel calculators for predicting which patients admitted to the hospital with COVID-19 are at greatest risk of requiring mechanical ventilation or of in-hospital death have been developed and validated by researchers. More...01 Mar 2021
Johnson & Johnson COVID-19 Vaccine Becomes First Single-Shot Vaccine to Receive FDA Emergency Use Authorization
Johnson & Johnson’s (New Brunswick, NJ, USA) single-dose COVID-19 vaccine, developed by its Janssen Pharmaceutical Companies (Beerse, Belgium), has become the first single-shot vaccine to be granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA). More...01 Mar 2021
In Other News
Blood Tests Can Predict ICU Admission Even Before COVID-19 Patients Become Critically Ill
Heart MRI Scans Can Enable More Accurate COVID-19 Diagnoses and Target Treatments More Effectively
New Approach to Pooled COVID-19 Testing Could Be Highly Effective in Curbing SARS-CoV-2 Pandemic
Stamp-Sized Microfluidic Chip Uses Programmed Magnetic Nanobeads and Off-the-Shelf Cellphone to Diagnose COVID-19
On-Skin, Wearable Bioelectronic Device Could Aid Early Detection of COVID-19
Rapid Point-of-Care COVID-19 Antigen Test Based on Waveguide Technology Could Deliver Results in Under Six Minutes
New COVID-19 Test to Scan Saliva or Nasal Swabs Using Specialized Probes for Detecting SARS-CoV-2 RNA Sequences
Siemens Lab-Based SARS-CoV-2 Antigen Assay (CoV2Ag) Obtains CE Mark for Use with Its High-Throughput Analyzers
Machine Learning Model Uncovers Genetic Predisposition to Severe COVID-19
Mathematical Model Estimates False-Negative Rate for COVID-19 Tests
Two New Diagnostic Tests Can Differentiate Between COVID-19 Variants and Multiple Viruses with Rapid Turnaround Times
PerkinElmer Launches New Highly Sensitive Point of Care COVID-19 Antigen Test for Mass Screening
People with Absence of Natural Killer Cell Receptor Most Likely to Develop Severe COVID-19, Finds Study
Pfizer-BioNTech COVID-19 Vaccine Can Be Stored at Standard Freezer Temperature, Claims Submission for Revision of FDA EUA
World’s First AI Rapid Antigen Test System for COVID-19 Delivers Highly Accurate Results on Smartphone Within 5-8 Minutes
Antibody-Based COVID-19 Treatments Work Best in Concert with Immune Cells, Finds Study
D614G Mutation Makes SARS-CoV-2 Up to Eight Times More Infectious than Initial Virus that Originated in China
Agilent Launches New Immunoassay Kit to Detect SARS-CoV-2 Antibodies
First-Ever Highly Sensitive Antibody Tests Could Detect Infection with All Known Human Coronaviruses, Including New SARS-CoV-2 Variants
New Diagnostic Device Identifies COVID-19 Patients at Risk of Potentially Lethal Cytokine Storm
Advanced X-Ray Imaging Technique for Detecting Breast Cancer Could Also Diagnose COVID-19
Artificial Intelligence Algorithm Predicts Individual Mortality Risk for COVID-19 Patients
Breakthrough Respiration Treatment to Be Used on Critically Ill COVID-19 Patients